Sarsia Seed Management is a venture capital and private equity firm investing in early-stage energy, clean technology, biotechnology, biotechnology, and life science companies that is headquartered in Bergen, Hordaland and was founded in 2006. According to the firms LinkedIn profile (as of December 2019), they have made 22 investments, have 14 companies in their portfolio, one IPO, and 5 exits.
Notable investments made by Sarisa Seed Management include: Aquiloz, Delante, Xsens Flow Solutions, Nisonic, Trisense as, BerGenBio, Vaccibody, Apim Therapeutics, Avexxin, Prophylix, Sorbwater Technology, Pluvia, Sono Clear, Heimdall Power, Med-Storm Innovation, SeaFarm Solutions, Sea-Hawk, Windsim, ScreenCancer, and Blue Limit.
The Sarisa Seed Fund I was established in 2006 with $50 million in funding. The fund focused on investing in energy, technology, biotechnology, life science, and marine technology companies. The fund made 22 investments and 9 exits.
The Sarisa Seed Fund II was established in 2017 with $55 million in funding for investing in energy, technology, biotechnology, and life science companies. The firm plans on using their Sarisa Seed Fund II for making approximately 15-20 investments.